+91-8668442535

Wearable Injector Devices Market, By Injector Type (On Body & Off Body), By Usage (Disposable, Reusable), By Technology (Spring Based, Motor-Driven, Rotary Pump, Expanding Battery, Smart Connectivity Options & Others) & By Therapeutic Area (Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Disorder, Infectious Diseases & Others) - Growth, Future Prospects, and Competitive Analysis, 2017 -2025

The report titled "Wearable Injector Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall wearable injector devices market, along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of wearable injector device market segments based on injector type, usage, technology, therapeutic area end users, and different geographies further segmented by countries. Wearable injectors, also known as large-volume injectors, are the latest trend in the injectable device market. These devices permit the injection of large volumes of dosage via the subcutaneous route for a long duration, which offers benefits to drug developers, clinicians, and patients. The majority of biologic therapeutics are delivered parenterally, where high-volume injection doses are frequently required. The development of biologic therapeutics is growing at a faster pace compared to other medication forms, and this growth in the biologic market is said to be driving the emergence of wearable injectors.

For the purpose of this study, the global wearable injector device market is segmented on the basis of injector type, usage, smart connectivity options, technology, therapeutic area, and end users. Injectors are further classified as On Body and Off Body. Based on usage, devices are further segmented into disposable and reusable ones. By technology, devices are segmented into spring-based, motor-driven, rotary pumps, expanding batteries, smart connectivity options, etc. Therapeutic area devices are segmented into oncology, diabetes, cardiovascular diseases, autoimmune disorders, infectious diseases, and others. Market estimates and forecasts for these segments are provided in US$ Mn, along with the respective compounded annual growth rates (CAGRs) for the period 2017-2025, with 2016 as the base year.

The geographical segmentation of the global wearable injector devices market comprised regions such as North America, Europe, Asia-Pacific, Latin America & the Middle East, and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. The market size and forecast for these segments during 2015–2025 and their CAGRs for the period 2017–2025 are provided in this report.

The wearable injector devices market is observed as the most diversified and competitive market, comprising a large number of players. The market is dominated by several players, depending on their major competencies. SteadyMed Therapeutics, Inc., UNI LIFE CORPORATION, Sensile Medical AG, Insulet Corporation, Enable Injections, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Ypsomed, Amgen, Buhler Motor GmbH, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., CeQur SA., and Others are the key players in this market.

Based on the type of injector, the global wearable injector devices market is segmented as follows:

  • On body (adhesive patch)
  • Off the body (belt)

The on-body type of injector (an adhesive patch) is said to predominate the market as it ensures ease of application and does not hamper the patient's daily lifestyle. This kind of injector has the benefit of allowing dose adjustment in terms of frequency and volume, water resistance, and decreased healthcare costs. The off-body type of injector is slowly gaining demand owing to the problems with adhesive patches, such as skin irritation, fitting issues, and painful device removal.

Based on the usage of the device, the global wearable injector devices market is segmented as follows:

  • Semi-reusable injectors
  • Disposable Injectors

Within this segment, semi-reusable injectors are presumed to gain a larger market share compared to disposable injectors owing to the advantage of not completely discarding the device, thus making it more cost-efficient in comparison to disposable injectors. The disposable type may gain profits in those therapeutic areas where the medication is of a shorter duration.

Based on the technology of the device, the global wearable injector devices market is segmented as follows:

  • Spring Based
  • Motor-Driven
  • Rotary Pump
  • Expanding Battery
  • Smart Connectivity Options
  • Others

Devices with spring-based technology are presumed to account for a larger market share owing to the increased demand for adhesive patches. Adhesive patches are convenient to use and ensure accurate dose administration subcutaneously. The demand for devices with motor-driven technology is expected to become dominant in the wearable injector devices market between 2017 and 2025, owing to their ability to deliver accurate doses and self-administer doses at predetermined set timings.

Based on therapeutic area, the global wearable injector devices market is segmented as follows:

  • Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Disorders
  • Infectious Diseases
  • Others

In comparison with all the chronic diseases mentioned in this segment, oncology predominates this segment and could grab a major share in the wearable injector devices market, owing to its rising prevalence along with an increased approach for self-administration of medication in order to curb hospitalization costs. Diabetes holds the second position in this segment, as wearable injectors have advantages over insulin pumps. Other conditions would also slowly adopt the use of wearable injectors due to key factors such as patient friendliness and reduced hospital costs. The demand would increase further once the reimbursement policies for these devices were made more lenient.

For the purpose of this study, the global wearable injector devices market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Wearable injectors are the most recent technological advancements that allow large-volume doses to be injected subcutaneously. Based on geography, the wearable injector devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among the mentioned regions, North America shows greater dominance in the wearable injector device market. A constant rising prevalence of chronic diseases, an increase in technological development with smart connectivity options that help remote monitoring by caregivers, easy access to the latest technology, and developed healthcare infrastructure are the factors driving this market to positive growth. Asia-Pacific is expected to grow at a positive rate between 2017 and 2025, thanks to factors such as the increased prevalence of a technologically advanced industrial pool in countries such as Japan and China. Developing nations such as Latin America and the Middle East, and Africa show sluggish growth in the forecast period, which could be attributed to the slower acceptability and availability of developed technologies.

Frequently Asked Questions:

The market for Wearable Injector Devices Market is expected to reach USD 10,027.1 Mn By 2025.

The Wearable Injector Devices Market is expected to see significant CAGR growth over the coming years, at 14.4%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

SteadyMed Therapeutics, Inc., UNI LIFE CORPORATION, Sensile Medical AG, Insulet Corporation, Enable Injections, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Ypsomed, Amgen, Buhler Motor GmbH, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., CeQur SA. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58775
Report Format:   PDF
Pages:   120
Rating:    4.8 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support